Loss of an animal drug product can have adverse effects on animal health, animal welfare and food safety. Before withdrawing approval of an animal drug product or taking action that may result in a product being withdrawn from the market by the drug sponsor, the AVMA urges FDA-CVM to balance the magnitude of the adverse effects against the risk that may result from continued availability of the drug.